Limula

💡 Limula is a Deep Tech Pioneer! (according to Hello Tomorrow) Our disruptive approach to the production of CAR T-cell therapies was chosen amongst thousands of applications by their expert jury. In a nutshell: our team combines 'Swiss Made' engineering with life-saving 'living drugs'. If you want to learn more about our vision — making personalised cures accessible to patients, at scale — come meet our co-founders at the 10th Hello Tomorrow Global Summit on 13-14 March 2025 in Paris 🇫🇷 We look forward to engaging with fellow deep tech entrepreneurs and daring investors looking at supporting massively impactful projects. (link to event page in comment) #DeepTech #HTSummit2025 #CellTherapy #Manufacturing #Automation #Robotics

👀 Worth a detailed read! Reach out if you want to learn how we solve the cell therapy manufacturing challenge described below with a unique technology that is easy to adopt during R&D, robust during clinical trials and scalable after market approval. “One of the technical challenges during scale up is that the process developed to manufacture trial supplies is almost always different from the final process required for commercialization. As a result, positive clinical trial results mean developers must ‘double back’ to more scalable solutions, which can change the culture vessel, materials of contact, and even the media and reagents used to varying degrees.” via Genetic Engineering & Biotechnology News https://lnkd.in/eQDSbCqf

Our week in Dallas 🇺🇸 for Advanced Therapies Week #ATW25 was a success - A big thank you to everyone who came visit our booth or listen to our presentation! Looking forward to following up with all of you. Next stop: Munich 🇩🇪 for the DxPx Conference

Looking to automate your cell therapy manufacturing process? Our Head of Solutions Caroline Boudousquié will present our latest CAR T cell production data in Basel 🇨🇭 tomorrow at the Basel Cell Therapy Symposium. Come meet her at the poster session, or contact us by email to start a conversation: partnerships@limula.ch #CGT #celltherapy #CART #manufacturing #automation University of Basel University Hospital Basel SAKK Swiss Group for Clinical Cancer Research

📣 This week, we will unveil the solution Limula is bringing to market! Our CEO Luc Henry and BD Specialist Sarah de la Mota are in Dallas Texas 🇺🇸 for Phacilitate #ATW2025 Join us for our Tech Spotlight presentation or come by our booth #8 in the Innovation Zone. A big thank you to everyone who have booked meetings with us already!

Two of our co-founders Luc Henry and Thomas Eaton will be in San Francisco during #JPM25 📈 Cell and Gene Therapy manufacturing at scale, that is our mission 🤔 How? Reach out if you want to learn more!

⏳ Two week countdown to Phacilitate Advanced Therapies Week 2025 in Dallas 🇺🇸 📣 Are you a therapeutic developer looking to explore innovative CGT manufacturing solutions? We will present our product updates during the Tech Spotlight session on Wednesday January 22nd at 11am. We also have a booth in the Innovation Zone. Come talk to Sarah and Luc to learn more. Interested? Book a meeting via the event app or at partnerships@limula.ch.

Season's Greetings 🎄 from Lausanne 🇨🇭 We just shipped the latest edition of our quarterly newsletter! Nothing to add ;) you can read the update here 👉🏽 https://lnkd.in/dDhSGxm7 (and in case you have not subscribed yet, you should using link at the bottom of this page: https://limula.ch/contact/) #CGT #CellTherapy #Manufacturing #Automation

ICYMI: "The Counterattack - An immune cell treatment that fights cancer is now taking aim at autoimmune disease" Last month, Jennifer Couzin-Frankel wrote a very detailed piece for Science Magazine on the promise of CAR T cell for the treatment of Refractory Systemic Lupus Erythematosus. To give you an idea of the potential impact: the Lupus Foundation of America, Inc estimates that at least 5 million people around the world have some form of lupus, 90% of them women, with an average annual total treatment costs as high as $50,000 in the USA. The take home message: let's make sure highly-personalised Cell & Gene Therapies are soon accessible to all the patients who could benefit! https://lnkd.in/eGgQ78xT #CART #CGT #Automated #Manufacturing

📢 Fresh funding to support additional early adopters in 2025. Are you a clinical center, a biotech, or a CDMO looking to automate your cell therapy manufacturing processes? Reach out to learn more about our solution: partnerships@limula.ch We just received the news that - on top of our Seed round closed earlier this year - we can count on a Tech Growth loan of CHF 0.5 million from the FIT - Fondation pour l'Innovation Technologique. 🚀 Read more here ➡️ https://lnkd.in/ewYZvBeX    #CellTherapy #GeneTherapy #manufacturing #automation